Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Rats choose alcohol over social reward in an operant choice procedure
    Published on 2022-09-15
    3 years ago
  • Unique brain endothelial profiles activated by social stress promote cell adhesion, prostaglandin E2 signaling, hypothalamic–pituitary–adrenal axis modulation, and anxiety
    Published on 2022-09-14
    3 years ago
  • TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP-383856
    Published on 2022-09-13
    3 years ago
  • Trait anxiety is associated with amygdala expectation and caloric taste receipt response across eating disorders
    Published on 2022-09-13
    3 years ago
  • Racial discrimination associates with lower cingulate cortex thickness in trauma-exposed black women
    Published on 2022-09-13
    3 years ago
  • Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment
    Published on 2022-09-13
    3 years ago
  • PET imaging of kappa opioid receptors and receptor expression quantified in neuron-derived extracellular vesicles in socially housed female and male cynomolgus macaques
    Published on 2022-09-13
    3 years ago
« Previous 1 … 101 102 103 104 105 … 143 Next »
Journal of Psychopharmacology
  • The mGluR2/3 agonist LY379268 reverses NMDA receptor antagonist effects on cortical gamma oscillations and phase coherence, but not working memory impairments, in mice
    Published on 2019-10-03
    6 years ago
  • Caffeine improves text reading and global perception
    Published on 2019-10-03
    6 years ago
  • Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial
    Published on 2019-10-02
    6 years ago
  • Corrigendum to The Australian Drug Harms Ranking Study
    Published on 2019-10-02
    6 years ago
  • Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency
    Published on 2019-09-26
    6 years ago
  • Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression
    Published on 2019-09-26
    6 years ago
  • Social cognition impairments in long-term opiate users in treatment
    Published on 2019-09-26
    6 years ago
« Previous 1 … 101 102 103 104 105 … 123 Next »
European Neuropsychopharmacology
  • EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial
    Published on 2021-01-26
    4 years ago
  • Corrigendum to “Translating big data to better treatment in bipolar disorder – a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121–136]”
    Published on 2021-01-24
    4 years ago
  • Integrating genomics and transcriptomics: Towards deciphering ADHD
    Published on 2021-01-24
    4 years ago
  • Increased thin-spine density in frontal cortex pyramidal neurons in a genetic rat model of schizophrenia-relevant features
    Published on 2021-01-22
    4 years ago
  • Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers
    Published on 2021-01-22
    4 years ago
  • Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis
    Published on 2021-01-20
    4 years ago
  • Maternal ADHD medication use during pregnancy and the risk of ADHD in children: Importance of genetic predispositions and impact of using a sibling analysis
    Published on 2021-01-16
    4 years ago
« Previous 1 … 101 102 103 104 105 … 144 Next »

   Pharma Pub